Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.

The FDA has approved a new drug that promises a simpler and far more effective treatment for drug-resistant tuberculosis. But not everyone is celebrating. Doctors Without Borders has concerns about a ...

Finding out what drugs can be used to treat a patient with tuberculosis (TB) can be sped up by days or weeks, thanks to a new free online tool. The new TB-Profiler tool, developed by a team of ...

Tufts University researchers’ approach uncovers how TB treatments can best work together at the cellular level to speed better cures Tuberculosis (TB) is the world’s deadliest infectious disease—and ...

Please provide your email address to receive an email when new articles are posted on . Three all-oral 9-month treatments for drug-resistant tuberculosis were found to be noninferior to standard ...

Tuberculosis is both curable and preventable, yet each year, it still kills more people than any other infectious disease. One reason is that current treatments hinge on rifampicin, an antibiotic that ...

A new study in "Nature Medicine" estimates 2 million people are incorrectly told they have TB each year — and clinicians miss ...

The modification of the liposomal surface by incorporating negatively charged lipids (e.g., by dicetylphosphate [DCP] incorporation), seems to increase the AM affinity to capture anionic liposomes via ...